Researchers from the Wellcome Sanger Institute and the University of Cambridge (both UK) discovered the first Y chromosome specific gene, UTY acts as leukemia protective gene. This key progress was published in Nature Genetics recently. To accelerate the research of Aute Myeloid Leukemia (AML), GenScript would like to offer a FREE UTX or UTY ORF clone to our scientists.
Use Promotion Code ORF2018UT to enjoy free clone. Valid Until: 6/30/2018
Search for the latest version of your ORFs at GenScript now!
Where to target the version number? Example
Terms and conditions:
- Only domestic (US) and international customers, excluding Japan and China, are eligible to attend this promotion.
- This promotion is valid until Jun 30th, 2018, US-EST time zone.
- All customers can choose one clone listed in the above table for free. Other next-day shipping clones purchased with this free clone still can enjoy 50% discount.
- Please use promotion code "ORF2018UT" to enjoy the free clone.
- Customer is responsible for paying the shipping fee to receive the free and discounted ORF clones.
Acute Myeloid Leukemia (AML)
Acute myeloid leukemia (AML) is a cancer originating from the myeloid lineage of blood cells. The rapid growth of abnormal cells interferes with the function of normal blood cells, leading to a variety of severe symptoms which left untreated causes death. In 2015, it was reported that one million people were affected by AML across the globe, resulting in 147,000 deaths. Unfortunately, this number keeps increasing and expanding to younger adults and even children.
New Progress in the Protection Against AML
While there are treatments for AML, due to the complexity of this cancer, no cure is found yet. But recently scientists from the Wellcome Trust Sanger Institute discovered a new Y chromosome-specific gene, called UTY, which protects against the development of AML and other cancers. Deeper understanding of the mechanism beind this protection will give new hints on novel druggable targets toward curing AML and perhaps other cancers.